Hereditary cancer testing identifies specific germline mutations—such as BRCA1, BRCA2, or those associated with Lynch Syndrome—that are passed down through families. By identifying high-risk individuals before cancer develops, healthcare providers can implement intensive surveillance, chemoprevention, or risk-reducing surgeries, fundamentally shifting the oncology paradigm from reacti... https://www.databridgemarketresearch.com/nucleus/global-hereditary-cancer-testing-market